Association of angiotensin-converting enzyme insertion/deletion polymorphism with serum level and development of pulmonary complications following esophagectomy

Annals of Surgery

Volumn 241, Issue 4, 2005, Pages 659-665

  Lee, Jang Ming ^a   Lo, An Chi ^b   Yang, Shi Yi ^b   Tsau, Huei Shian ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ALLELE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA POLYMORPHISM; EMPYEMA; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE INSERTION; GENOTYPE; HIGH RISK PATIENT; HUMAN; HYPOALBUMINEMIA; LEUKOCYTE; LUNG FUNCTION; LUNG INFILTRATE; LUNG INJURY; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RESPIRATORY FAILURE; RISK FACTOR; SENESCENCE;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; LOGISTIC MODELS; LUNG DISEASES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 15444370455     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000157132.08833.98     Document Type: Article

References (21)

1. Walsh TN, Noonan N, Hollywood D, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996;335:462-467.
2. Swisher SG, Hunt KK, Holmes EC, et al. Changes in the surgical management of esophageal cancer from 1970 to 1993. Am J Surg. 1995;169:609-614.
3. Ferguson MK, Durkin AE. Preoperative prediction of the risk of pulmonary complications after esophagectomy for cancer. J Thorac Curdiovasc Surg. 2002;123:661-669.
4. Fan ST, Lau WY, Yip WC, et al. Prediction of postoperative pulmonary complications in oesophagogastric cancer surgery. Br J Surg. 1987;74:408-410.
5. Nagawa H, Kobori O, Muto T. Prediction of pulmonary complications after transthoracic oesophagectomy. Br J Surg. 1994;81:860-862.
6. Karl RC, Schreiber R, Boulware D, et al. Factors affecting morbidity, mortality, and survival in patients undergoing Ivor Lewis esophagogastrectomy. Ann Surg. 2000;231:635-643.
7. Kuwano H, Sumiyoshi K, Sonoda K, et al. Relationship between preoperative assessment of organ function and postoperative morbidity in patients with oesophageal cancer. Eur J Surg. 1998;164:581-586.
8. van Sandick JW, Gisbertz SS, ten Berge IJ, et al. Immune responses and prediction of major infection in patients undergoing transhiatal or transthoracic esophagectomy for cancer. Ann Surg. 2003;237:35-43.
9. Tsukada K, Hasegawa T, Miyazaki T, et al. Predictive value of interleukin-8 and granulocyte elastase in pulmonary complication after esophagectomy. Am J Surg. 2001;181:167-171.
10. Wang R, Zagariya A, Ibarra-Sunga O, et al. Angiotensin II induces apoptosis in human and rat alveolar epithelial cells. Am J Physiol. 1999;276:L885-889.
11. Ruiz-Ortega M, Lorenzo O, Ruperez M, et al. Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms. Circ Res. 2000;86: 1266-1272.
12. Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86: 1343-1346.
13. Marshall RP, Webb S, Bellingan GJ, et al. Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med. 2002;166:646-650.
14. Benessiano J, Crestani B, Mestari F, et al. High frequency of a deletion polymorphism of the angiotensin-converting enzyme gene in asthma. J Allergy Clin Immunol. 1997;99:53-57.
15. Maier LA, Raynolds MV, Young DA, et al. Angiotensin-1 converting enzyme polymorphisms in chronic beryllium disease. Am J Respir Crit Care Med. 1999;159:1342-1350.
16. Morrison CD, Papp AC, Hejmanowski AQ, et al. Increased D allele frequency of the angiotensin-converting enzyme gene in pulmonary fibrosis. Hum Pathol. 2001;32:521-528.
17. Maliarik MJ, Rybicki BA, Malvitz E, et al. Angiotensin-converting enzyme gene polymorphism and risk of sarcoidosis. Am J Respir Crit Care Med. 1998;158:1566-1570.
18. Pietinalho A, Furuya K, Yamaguchi E, et al. The angiotensin-converting enzyme DD gene is associated with poor prognosis in Finnish sarcoidosis patients. Eur Respir J. 1999;13:723-726.
19. Lindpaintner K, Pfeffer MA, Kreutz R, et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med. 1995;332:706-711.
20. Avendano CE, Flume PA, Silvestri GA, et al. Pulmonary complications after esophagectomy. Ann Thorac Surg. 2002;73:922-926.
21. Japanese Committee for Registration of Esophageal Carcinoma. A proposal for a new TNM classification of esophageal carcinoma: Japanese Committee for Registration of Esophageal Carcinoma. Jpn J Clin Oncol. 1985;15:625-636.